PURPOSE: To determine risk factors for the development of gallstones and the prevalence of related cholecystectomy in children following hematopoietic cell transplantation (HCT). PATIENTS AND METHODS: A retrospective chart review of 1343 patients aged below 18 years old who survived at least 1 year after HCT from 1969 to 2011 was performed. Multivariate Cox regression models were used to estimate the hazard ratio (HR) of risk factors associated with gallstones. RESULTS: Gallstones developed in 91 patients, a median of 3.5 (range, 0.1 to 30.9) years after HCT at 16.3 (range, 0.8 to 44.2) years of age, with a 40-year cumulative incidence of 11%. At initial diagnosis, 61 (67%) patients were symptomatic and 30 (23%) had incidental gallstones. Risk factors associated with gallstones included autologous transplant (HR=2.7, P=0.02), unrelated donor (HR=2.0, P=0.05), grade 3 to 4 acute graft-versus-host disease (GVHD) (HR=2.2, P=0.03), chronic GVHD (HR=2.0, P=0.05), second transplant (HR=2.3, P=0.03), diabetes (HR=2.2, P=0.05), and estrogen therapy (HR=1.8, P=0.03). Fifty-six patients underwent cholecystectomy. The prevalence of cholecystectomy among 853 surviving patients was 5.2%. CONCLUSIONS: Childhood HCT patients have an increased risk of developing gallstones.
PURPOSE: To determine risk factors for the development of gallstones and the prevalence of related cholecystectomy in children following hematopoietic cell transplantation (HCT). PATIENTS AND METHODS: A retrospective chart review of 1343 patients aged below 18 years old who survived at least 1 year after HCT from 1969 to 2011 was performed. Multivariate Cox regression models were used to estimate the hazard ratio (HR) of risk factors associated with gallstones. RESULTS:Gallstones developed in 91 patients, a median of 3.5 (range, 0.1 to 30.9) years after HCT at 16.3 (range, 0.8 to 44.2) years of age, with a 40-year cumulative incidence of 11%. At initial diagnosis, 61 (67%) patients were symptomatic and 30 (23%) had incidental gallstones. Risk factors associated with gallstones included autologous transplant (HR=2.7, P=0.02), unrelated donor (HR=2.0, P=0.05), grade 3 to 4 acute graft-versus-host disease (GVHD) (HR=2.2, P=0.03), chronic GVHD (HR=2.0, P=0.05), second transplant (HR=2.3, P=0.03), diabetes (HR=2.2, P=0.05), and estrogen therapy (HR=1.8, P=0.03). Fifty-six patients underwent cholecystectomy. The prevalence of cholecystectomy among 853 surviving patients was 5.2%. CONCLUSIONS: Childhood HCT patients have an increased risk of developing gallstones.
Authors: E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner Journal: N Engl J Med Date: 1975-04-17 Impact factor: 91.245
Authors: H J Deeg; D Lin; W Leisenring; M Boeckh; C Anasetti; F R Appelbaum; T R Chauncey; K Doney; M Flowers; P Martin; R Nash; G Schoch; K M Sullivan; R P Witherspoon; R Storb Journal: Blood Date: 1997-05-15 Impact factor: 22.113
Authors: Ann E Woolfrey; Claudio Anasetti; Barry Storer; Kristine Doney; Laurie A Milner; Eric L Sievers; Paul Carpenter; Paul Martin; Effie Petersdorf; Frederick R Appelbaum; John A Hansen; Jean E Sanders Journal: Blood Date: 2002-03-15 Impact factor: 22.113
Authors: H Joachim Deeg; Barry Storer; John T Slattery; Claudio Anasetti; Kristine C Doney; John A Hansen; Hans-Peter Kiem; Paul J Martin; Effie Petersdorf; Jerald P Radich; Jean E Sanders; Howard M Shulman; Edus H Warren; Robert P Witherspoon; Eileen M Bryant; Thomas R Chauncey; Lisa Getzendaner; Rainer Storb; Frederick R Appelbaum Journal: Blood Date: 2002-08-15 Impact factor: 22.113
Authors: K Scott Baker; James G Gurney; Kirsten K Ness; Ravi Bhatia; Stephen J Forman; Liton Francisco; Philip B McGlave; Leslie L Robison; David S Snyder; Daniel J Weisdorf; Smita Bhatia Journal: Blood Date: 2004-06-01 Impact factor: 22.113
Authors: E R Nemecek; T A Gooley; A E Woolfrey; P A Carpenter; D C Matthews; J E Sanders Journal: Bone Marrow Transplant Date: 2004-11 Impact factor: 5.483
Authors: J Stief; H U Stempfle; M Götzberger; P Uberfuhr; M Köpple; P Lehnert; C Kaiser; Uwe Schiemann Journal: Eur J Med Res Date: 2009-05-14 Impact factor: 2.175
Authors: Przemysław Gałązka; Krzysztof Czyżewski; Anna Szaflarska-Popławska; Robert Dębski; Anna Krenska; Jan Styczyński Journal: Cent Eur J Immunol Date: 2019-09-30 Impact factor: 2.085